BDBM50147993 2-Cyclohexyl-N-{2-[4-(2',4'-dichloro-biphenyl-3-yl)-piperidin-1-yl]-2-oxo-ethyl}-2-guanidino-acetamide::CHEMBL105518
SMILES: [#7]\[#6](-[#7])=[#7]/[#6@H](-[#6]-1-[#6]-[#6]-[#6]-[#6]-[#6]-1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-1-[#6]-[#6]-[#6](-[#6]-[#6]-1)-c1cccc(c1)-c1ccc(Cl)cc1Cl
InChI Key: InChIKey=GGPYGVTZDCLLHA-AREMUKBSSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interleukin-2 receptor alpha chain (Mus musculus) | BDBM50147993 (2-Cyclohexyl-N-{2-[4-(2',4'-dichloro-biphenyl-3-yl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sunesis Pharmaceuticals Inc. Curated by ChEMBL | Assay Description Concentration required to inhibit mouse interleukin-2 alpha receptor was determined by SPA assay | J Med Chem 47: 3111-30 (2004) Article DOI: 10.1021/jm049967u BindingDB Entry DOI: 10.7270/Q2TQ6280 | |||||||||||
More data for this Ligand-Target Pair |